Summary
Teradyne, Inc. (TER) reported its third quarter and nine-month results for the period ending September 29, 2013. For the nine months, net revenues decreased to $1.14 billion from $1.41 billion in the prior year, primarily driven by declines in Semiconductor Test and System Test segments, with lower demand in the hard disk drive market impacting System Test. Despite revenue challenges, gross profit as a percentage of revenue improved to 56.8% from 54.0% year-over-year, reflecting favorable product mix and lower inventory provisions. Cash and cash equivalents saw a significant increase, rising to $572.9 million from $338.9 million at the end of 2012, fueled by strong operating cash flow. The company ended the period with a healthy liquidity position. Teradyne completed the acquisition of ZTEC Instruments, Inc. and the sale of its equity interest in Empirix Inc. in October 2013, which are expected to impact future financial performance.
Financial Highlights
49 data points| Revenue | $433.38M |
| Cost of Revenue | $179.08M |
| Gross Profit | $254.29M |
| SG&A Expenses | $72.92M |
| Operating Expenses | $160.79M |
| Operating Income | $93.51M |
| Interest Expense | $6.49M |
| Net Income | $69.46M |
| EPS (Basic) | $0.36 |
| EPS (Diluted) | $0.29 |
| Shares Outstanding (Basic) | 191.31M |
| Shares Outstanding (Diluted) | 235.83M |
Key Highlights
- 1Total net revenues for the nine months ended September 29, 2013, decreased to $1.14 billion from $1.41 billion in the same period of 2012.
- 2Gross profit margin improved to 56.8% for the nine months ended September 29, 2013, from 54.0% in the prior year's period.
- 3Cash and cash equivalents increased significantly to $572.9 million as of September 29, 2013, from $338.9 million at December 31, 2012.
- 4Net income for the nine months ended September 29, 2013, was $142.6 million, down from $233.6 million in the comparable period of 2012.
- 5Operating expenses increased for the nine-month period, with Engineering & Development up to $199.4 million from $193.1 million, and Selling & Administrative expenses rising to $210.0 million from $207.7 million.
- 6The company reported a book-to-bill ratio of 0.6 for the total company in Q3 2013, compared to 0.5 in Q3 2012, indicating a slight improvement in new orders relative to sales.
- 7Teradyne completed the acquisition of ZTEC Instruments, Inc. and the divestiture of its equity interest in Empirix Inc. in October 2013.